Bushinsky DA - Search Results

1

When is it appropriate to order an ionized calcium?

Calvi LM, Bushinsky DA. Calvi LM, et al. Among authors: bushinsky da. J Am Soc Nephrol. 2008 Jul;19(7):1257-60. doi: 10.1681/ASN.2007121327. Epub 2008 Jan 23. J Am Soc Nephrol. 2008. PMID: 18216306

2

Phosphate binders: hold the calcium?

Bushinsky DA. Bushinsky DA. Clin J Am Soc Nephrol. 2006 Jul;1(4):695-6. doi: 10.2215/CJN.00950306. Epub 2006 May 3. Clin J Am Soc Nephrol. 2006. PMID: 17699274 No abstract available.

3

Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA. Krieger NS, et al. Among authors: bushinsky da. J Am Soc Nephrol. 2015 Dec;26(12):3001-8. doi: 10.1681/ASN.2014121223. Epub 2015 Apr 8. J Am Soc Nephrol. 2015. PMID: 25855777 Free PMC article.

4

Making sense of the latest advice on vitamin D therapy.

Monk RD, Bushinsky DA. Monk RD, et al. Among authors: bushinsky da. J Am Soc Nephrol. 2011 Jun;22(6):994-8. doi: 10.1681/ASN.2011030251. Epub 2011 May 26. J Am Soc Nephrol. 2011. PMID: 21617120

5

Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.

Bushinsky DA, Asplin JR. Bushinsky DA, et al. J Am Soc Nephrol. 2005 Feb;16(2):417-24. doi: 10.1681/ASN.2004070543. Epub 2005 Jan 12. J Am Soc Nephrol. 2005. PMID: 15647340

6

Molecular mechanisms of primary hypercalciuria.

Frick KK, Bushinsky DA. Frick KK, et al. Among authors: bushinsky da. J Am Soc Nephrol. 2003 Apr;14(4):1082-95. doi: 10.1097/01.asn.0000062960.26868.17. J Am Soc Nephrol. 2003. PMID: 12660344 Review. No abstract available.

7

Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats.

Hoopes RR Jr, Middleton FA, Sen S, Hueber PA, Reid R, Bushinsky DA, Scheinman SJ. Hoopes RR Jr, et al. Among authors: bushinsky da. J Am Soc Nephrol. 2006 May;17(5):1292-304. doi: 10.1681/ASN.2005080828. Epub 2006 Apr 12. J Am Soc Nephrol. 2006. PMID: 16611718

8

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.

Bushinsky DA, Rossignol P, Spiegel DM, Benton WW, Yuan J, Block GA, Wilcox CS, Agarwal R. Bushinsky DA, et al. Am J Nephrol. 2016;44(5):404-410. doi: 10.1159/000451067. Epub 2016 Oct 27. Am J Nephrol. 2016. PMID: 27784004 Free article. Clinical Trial.

9

Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Krieger NS, Asplin JR, Granja I, Ramos FM, Flotteron C, Chen L, Wu TT, Grynpas MD, Bushinsky DA. Krieger NS, et al. Among authors: bushinsky da. J Am Soc Nephrol. 2019 Jul;30(7):1163-1173. doi: 10.1681/ASN.2018101066. Epub 2019 May 17. J Am Soc Nephrol. 2019. PMID: 31101664 Free PMC article.

10

Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor.

Bushinsky DA, Block GA, Martin KJ, Bell G, Huang S, Sun Y, Spiegel DM, Walsh L, Mix TC, Kewalramani R. Bushinsky DA, et al. Am J Nephrol. 2015;42(5):379-88. doi: 10.1159/000442754. Epub 2015 Dec 19. Am J Nephrol. 2015. PMID: 26684933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters